Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults

Completed · Phase 3

Conditions studied: Attention Deficit Disorder

In brief

This is a placebo controlled study evaluating the efficacy and safety of medication in adults with Attention-Deficit Hyperactivity Disorder (ADHD).

Key facts

Study ID

NCT00048360

Run by

GlaxoSmithKline

People needed

162

Starts

2002-10-01

Expected to finish

2003-06-01

Last updated by the study team

2013-02-12

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must be diagnosed with ADHD.

You may not qualify if…

• Patient has a current or past history of seizure disorder, brain injury, anorexia nervosa or bulimia.
• Patient has a current diagnosis of Major Depressive Disorder (MDD).
• Patient has a current primary diagnosis of, or received treatment for, Panic Disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD) or Acute Stress Disorder within the previous 12 months.
• Patient has a lifetime diagnosis of bipolar disorder, schizophrenia or other psychotic disorders.
• Patient has a positive urine test at screening for presence of illicit drugs or alcohol abuse during the past 12 months.

Where it is running

• GSK Clinical Trials Call Center — Phoenix, Arizona, United States
• GSK Clinical Trials Call Center — Chula Vista, California, United States
• GSK Clinical Trials Call Center — Lafayette, California, United States
• GSK Clinical Trials Call Center — Northridge, California, United States
• GSK Clinical Trials Call Center — Spring Valley, California, United States
• GSK Clinical Trials Call Center — West Palm Beach, Florida, United States
• GSK Clinical Trials Call Center — Paducah, Kentucky, United States
• GSK Clinical Trials Call Center — Rockville, Maryland, United States
• GSK Clinical Trials Call Center — Cambridge, Massachusetts, United States
• GSK Clinical Trials Call Center — Worcester, Massachusetts, United States
• GSK Clinical Trials Call Center — Omaha, Nebraska, United States
• GSK Clinical Trials Call Center — Chapel Hill, North Carolina, United States
• GSK Clinical Trials Call Center — Beachwood, Ohio, United States
• GSK Clinical Trials Call Center — Cincinnati, Ohio, United States
• GSK Clinical Trials Call Center — Portland, Oregon, United States
• GSK Clinical Trials Call Center — Bellaire, Texas, United States
• GSK Clinical Trials Call Center — Houston, Texas, United States
• GSK Clinical Trials Call Center — Salt Lake City, Utah, United States
• GSK Clinical Trials Call Center — Burlington, Vermont, United States
• GSK Clinical Trials Call Center — Woodstock, Vermont, United States
• GSK Clinical Trials Call Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.